Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 1,187,984 |
|
|||||
| News | - | ||||||
| Day High | 9.57 | Low High |
|||||
| Day Low | 8.59 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Replimune Group Inc | REPL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.19 | -2.11% | 8.82 | 18:44:40 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.15 | 8.59 | 9.57 | 8.82 | 9.01 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,556 | 1,187,984 | $ 9.03 | $ 10,731,064 | - | 4.92 - 24.81 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:53:54 | 10 | $ 9.26 | USD |
Replimune Group Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 539.6M | 61.39M | - | 0 | -174.28M | -2.84 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Replimune News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical REPL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.10 | 9.57 | 4.93 | 7.84 | 2,945,878 | 3.72 | 72.94% |
| 1 Month | 6.92 | 9.57 | 4.92 | 6.84 | 1,430,183 | 1.90 | 27.46% |
| 3 Months | 8.08 | 9.57 | 4.92 | 6.98 | 981,161 | 0.74 | 9.16% |
| 6 Months | 7.33 | 9.57 | 4.92 | 7.73 | 1,364,028 | 1.49 | 20.33% |
| 1 Year | 22.56 | 24.81 | 4.92 | 10.36 | 1,110,348 | -13.74 | -60.90% |
| 3 Years | 32.72 | 40.22 | 4.92 | 15.22 | 617,549 | -23.90 | -73.04% |
| 5 Years | 12.74 | 54.85 | 4.92 | 19.01 | 473,935 | -3.92 | -30.77% |
Replimune Description
| Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. |
